Jordi Ochando

Jordi Ochando

Icahn School of Medicine at Mount Sinai

H-index: 47

North America-United States

About Jordi Ochando

Jordi Ochando, With an exceptional h-index of 47 and a recent h-index of 37 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai,

His recent articles reflect a diverse array of research interests and contributions to the field:

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome …

Trained immunity—basic concepts and contributions to immunopathology

Maintenance of potent cellular and humoral immune responses in long-term hemodialysis patients after 1273-mRNA SARS-CoV-2 vaccination

Cellular and humoral responses follow-up for 8 months after vaccination with mRNA-based anti-SARS-CoV-2 vaccines

Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation

Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

Development of potent cellular and humoral immune responses in long-term hemodialysis patients after 1273-mRNA SARS-CoV-2 vaccination

Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases

Jordi Ochando Information

University

Position

MSSM

Citations(all)

11247

Citations(since 2020)

6668

Cited By

6821

hIndex(all)

47

hIndex(since 2020)

37

i10Index(all)

67

i10Index(since 2020)

64

Email

University Profile Page

Icahn School of Medicine at Mount Sinai

Google Scholar

View Google Scholar Profile

Top articles of Jordi Ochando

Title

Journal

Author(s)

Publication Date

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome …

Cytotherapy

Cristina Ferreras

Clara Hernández-Blanco

Alejandro Martín-Quirós

Karima Al-Akioui-Sanz

Marta Mora-Rillo

...

2024/1/1

Trained immunity—basic concepts and contributions to immunopathology

Jordi Ochando

Willem JM Mulder

Joren C Madsen

Mihai G Netea

Raphaël Duivenvoorden

2023/1

Maintenance of potent cellular and humoral immune responses in long-term hemodialysis patients after 1273-mRNA SARS-CoV-2 vaccination

Pharmaceuticals

Maria Gonzalez-Perez

Jana Baranda

Marcos J Berges-Buxeda

Patricia Conde

Mayte Pérez-Olmeda

...

2023/4/11

Cellular and humoral responses follow-up for 8 months after vaccination with mRNA-based anti-SARS-CoV-2 vaccines

Biomedicines

Sergio Gil-Manso

Diego Carbonell

Verónica Astrid Pérez-Fernández

Rocío López-Esteban

Roberto Alonso

...

2022/7/12

Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation

Scientific reports

Yohana C Toner

Adam A Ghotbi

Sonum Naidu

Ken Sakurai

Mandy MT van Leent

...

2022/4/13

Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

Nature biotechnology

Megan Schwarz

Denis Torre

Daniel Lozano-Ojalvo

Anthony T Tan

Tommaso Tabaglio

...

2022/11

Development of potent cellular and humoral immune responses in long-term hemodialysis patients after 1273-mRNA SARS-CoV-2 vaccination

Frontiers in Immunology

Maria Gonzalez-Perez

Maria Montes-Casado

Patricia Conde

Isabel Cervera

Jana Baranda

...

2022/3/23

Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases

Pediatric Rheumatology

Clara Udaondo

Carmen Cámara

Laura Miguel Berenguel

Rosa Alcobendas Rueda

Celia Muñoz Gómez

...

2022/8/13

Alicante-Winter Immunology Symposium in Health (A-Wish) and the Boulle-SEI awards: A collaboration between the Spanish Society for immunology, the University of Alicante and …

Jordi Ochando

Carmen Camara

Leighton Durham

Jose Miguel Sempere

Marcos Lopez-Hoyos

2022

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

EClinicalMedicine

Javier García-Pérez

María González-Pérez

María Castillo de la Osa

Alberto M Borobia

Luis Castaño

...

2022/8/1

VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment

Vaccine

Jon Salmanton-García

Fiona A Stewart

Sarah Heringer

Markela Koniordou

Elena Álvarez-Barco

...

2022/7/29

A modular approach toward producing nanotherapeutics targeting the innate immune system

Science advances

Mandy MT van Leent

Anu E Meerwaldt

Alexandre Berchouchi

Yohana C Toner

Marianne E Burnett

...

2021/3/5

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

Cell reports

Daniel Lozano-Ojalvo

Carmen Camara

Eduardo Lopez-Granados

Pilar Nozal

Lucía del Pino-Molina

...

2021/8/24

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

The Lancet

Alberto M Borobia

Antonio J Carcas

Mayte Pérez-Olmeda

Luis Castaño

María Jesús Bertran

...

2021/7/10

Trained immunity, tolerance, priming and differentiation: distinct immunological processes

Nature immunology

Maziar Divangahi

Peter Aaby

Shabaana Abdul Khader

Luis B Barreiro

Siroon Bekkering

...

2021/1

Inflammatory Lesions: Cyclic Arginine–Glycine–Aspartate‐Decorated Lipid Nanoparticle Targeting toward Inflammatory Lesions Involves Hitchhiking with Phagocytes (Adv. Sci. 13/2021)

Advanced Science

Alexandros Marios Sofias

Geir Bjørkøy

Jordi Ochando

Linda Sønstevold

Maria Hegvik

...

2021/7

Cyclic arginine–glycine–aspartate‐decorated lipid nanoparticle targeting toward inflammatory lesions involves hitchhiking with phagocytes

Advanced Science

Alexandros Marios Sofias

Geir Bjørkøy

Jordi Ochando

Linda Sønstevold

Maria Hegvik

...

2021/7

The BCG vaccine for COVID-19: first verdict and future directions

Maria Gonzalez-Perez

Rodrigo Sanchez-Tarjuelo

Boris Shor

Estanislao Nistal-Villan

Jordi Ochando

2021/3/8

Induction of high levels of specific humoral and cellular responses to SARS-CoV-2 after the administration of Covid-19 mRNA vaccines requires several days

Frontiers in immunology

Sergio Gil-Manso

Diego Carbonell

Luis López-Fernández

Iria Miguens

Roberto Alonso

...

2021/10/4

Myeloid-derived suppressor cells in kidney transplant recipients and the effect of maintenance immunotherapy

Frontiers in Immunology

María Iglesias-Escudero

David Sansegundo-Arribas

Paloma Riquelme

David Merino-Fernández

Sandra Guiral-Foz

...

2020/4/30

See List of Professors in Jordi Ochando University(Icahn School of Medicine at Mount Sinai)